生物活性

• 描述Saredutant is a selective NK2 receptor antagonist.
• 临床研究

• NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
  NCT00415142	Depressive Disorder	Phase 3	Completed	-	United States, New Jersey ... more >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Croatia Sanofi-Aventis Administrative Office Zagreb, Croatia Czech Republic Sanofi-Aventis Administrative Office Praha, Czech Republic France Sanofi-Aventis Administrative Office Paris, France Mexico Sanofi-Aventis Administrative Office Mexico, Mexico Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation Sweden Sanofi-Aventis Administrative Office Bromma, Sweden Turkey Sanofi-Aventis Administrative Office Istanbul, Turkey Collapse <<
  NCT00531622	Major Depressive Disorder	Phase 3	Completed	-	United States, New Jersey ... more >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Argentina Sanofi-Aventis Administrative Office Buenos Aires, Argentina Finland Sanofi-Aventis Administrative Office Helsinki, Finland France Sanofi-Aventis Administrative Office Paris, France Mexico Sanofi-Aventis Administrative Office Mexico, Mexico Sweden Sanofi-Aventis Administrative Office Bromma, Sweden Collapse <<
  NCT00629551	Depressive Disorder, Major	Phase 3	Completed	-	United States, New Jersey ... more >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Chile Sanofi-Aventis Administrative Office Santiago, Chile Estonia Sanofi-Aventis Administrative Office Tallinn, Estonia Germany Sanofi-Aventis Administrative Office Berlin, Germany Korea, Republic of Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Mexico Sanofi-Aventis Administrative Office Mexico, Mexico Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation South Africa Sanofi-Aventis Administrative Office Midrand, South Africa Collapse <<

• 更多